Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety-Reference-Cited by-同舟云学术

Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety

Published:2001-01 Issue:1 Volume:119 Page:64S-94S
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Hirsh Jack,Warkentin Theodore E.,Shaughnessy Stephen G.,Anand Sonia S.,Halperin Jonathan L.,Raschke Robert,Granger Christopher,Ohman E. Magnus,Dalen James E.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference377 articles.

1. Correlation between structure and function of heparin;Rosenberg;Proc Natl Acad Sci USA,1979

2. The thromboplastic action of cephalin;McLean;Am J Physiol,1916

3. The inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin;Brinkhous;Am J Physiol,1939

4. Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis;Abildgaard;Scand J Clin Lab Invest,1968

5. The heparin-antithrombin system: a natural anticoagulant mechanism;Rosenberg,1994

Cited by 1177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thromboprophylaxis in oesophageal cancer patients—a study protocol for a randomised, controlled trial (TOP-RCT);Trials;2024-09-06

2. Measurement of heparin, direct oral anti‐coagulants and other non‐coumarin anti‐coagulants and their effects on haemostasis assays: A British Society for Haematology Guideline;British Journal of Haematology;2024-09-02

3. Time in Therapeutic Range of Unfractionated Heparin-Based Therapy in Critically Ill Patients with COVID-19 Pneumonia;Therapeutics and Clinical Risk Management;2024-09

4. Nano-anticoagulant based on carrier-free low molecular weight heparin and octadecylamine with an albumin shuttling effect;Nature Communications;2024-08-08

5. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08